to control tranquilizer-induced Parkinson-like side effects
COGENTIN® methanesulfonate (benztropine methanesulfonate)
'Cogentin' is effective in providing relief for many patients who develop tremor, restlessness, feelings of
tension and other Parkinson-like symptoms during tranquilizer treatment of mental disorders.
Dosage and administration: Recommended dosage is one-half to one tablet two or three times a day.
If higher doses are required, the patient should be closely observed and dosage adjusted as indicated.
When 'Cogentin' is used to offset the distressing Parkinson-like side effects caused by tranquilizing drugs,
adequate therapy with these drugs may usually be continued. Rarely, a decrease in dosage may be necessary.
Supplied: As 2 mg. quarterscored tablets in bottles of 100 and 1000.
Cogentin is a trade-mark of Merck & Co., Inc.
Merck Sharp & Dohme Division of Merck & Co., Inc., Philadelphia 1, PA.